Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07180797

Proficiency-Based Progression on Hugo Ras Robot for Learning Nerve-Sparing RARP: Feasibility Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
12 (estimated)
Sponsor
Orsi Academy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Feasibility study 1. To evaluate the feasibility of PBP training for nerve-sparing RARP on the Hugo Ras system 2. To assess time to proficiency for participants with varying experience 3. To identify challenges in PBP RARP training through observed errors and feedback

Detailed description

As robotic surgery advances, the emergence of new platforms such as the Hugo™ Robotic-Assisted Surgery System calls for robust training frameworks. Proficiency-Based Progression (PBP) provides a structured method to ensure skill acquisition through clearly defined, measurable benchmarks. This study evaluates the feasibility of implementing a PBP curriculum to train urologists in nerve-sparing robot-assisted radical prostatectomy (RARP) using the Hugo™ system. Twelve urologists and urology residents will participate, divided into three groups based on experience: Robotic-naïve Intermediate (Da Vinci experience only) Expert RARP surgeons (Da Vinci experience without prior Hugo exposure) The PBP training pathway comprises: Cognitive modules (e-learning with MCQ validation) Psychomotor skills training (device familiarization and basic surgical skills) Procedural training (nerve-sparing RARP on porcine models) Performance will be evaluated both in real time and via blinded video review. Primary endpoints include the time to reach proficiency in basic skills and procedural steps, analyzed by prior experience. Secondary endpoints encompass error profiles, participant and instructor feedback, and the feasibility of standardizing proficiency metrics.

Conditions

Timeline

Start date
2025-09-12
Primary completion
2026-02-01
Completion
2026-03-01
First posted
2025-09-18
Last updated
2025-09-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT07180797. Inclusion in this directory is not an endorsement.